Action APC.H ADVANCED PROTEOME THERAPEUTICS CORPORATION
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Advanced Proteome Therapeutics Corporation

Actions

APC.H

CA0076282098

Temps Différé Toronto S.E.
Autres places de cotation
 21:55:53 04/12/2023 		Varia. 5j. Varia. 1 janv.
0,005 CAD -.--% Graphique intraday de Advanced Proteome Therapeutics Corporation -.--% -.--%
2023 Advanced Proteome Therapeutics Corporation annonce ses résultats pour le troisième trimestre et les neuf mois clos le 30 avril 2023 CI
2023 Advanced Proteome Therapeutics Corporation annonce ses résultats pour le deuxième trimestre et le semestre clos le 31 janvier 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Canadian Investment Regulatory Organization Trading Halt - APC.H
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023
IIROC Trading Resumption - APC
IIROC Trading Halt - APC
Advanced Proteome Therapeutics Corporation agreed to Spin-Off Linceis Capital Corp.
Advanced Proteome Therapeutics Corporation announced that it has received CAD 0.0725 million in funding from Conation Capital
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the First Quarter Ended October 31, 2022
Advanced Proteome Therapeutics Corporation Appoints Mr. Cory Brandolini to the Board of Directors
Advanced Proteome Therapeutics Corporation Auditor Raises 'Going Concern' Doubt
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Full Year Ended July 31, 2022
ADVANCED PROTEOME THERAPEUTICS RECEIVES ISSUED PATENT
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022
Advanced Proteome Therapeutics up 28.5%, Receives Notice of Allowance for Patent Claims
Advanced Proteome Therapeutics Receives Notice of Allowance for Patent Claims
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the First Quarter Ended October 31, 2021
Advanced Proteome Therapeutics Corporation Auditor Raises 'Going Concern' Doubt
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Full Year Ended July 31, 2021
Advanced Proteome Therapeutics Provides Update on COVID Program
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action APC.H
  4. Actualités Advanced Proteome Therapeutics Corporation
  5. Autres langues